annual operating expenses:
$1.12B+$234.50M(+26.49%)Summary
- As of today (May 18, 2025), UTHR annual total operating expenses is $1.12 billion, with the most recent change of +$234.50 million (+26.49%) on December 31, 2024.
- During the last 3 years, UTHR annual operating expenses has risen by +$112.50 million (+11.17%).
- UTHR annual operating expenses is now -26.28% below its all-time high of $1.52 billion, reached on December 31, 2019.
Performance
UTHR Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$319.10M+$22.80M(+7.69%)Summary
- As of today (May 18, 2025), UTHR quarterly total operating expenses is $319.10 million, with the most recent change of +$22.80 million (+7.69%) on March 31, 2025.
- Over the past year, UTHR quarterly operating expenses has increased by +$70.60 million (+28.41%).
- UTHR quarterly operating expenses is now -67.75% below its all-time high of $989.40 million, reached on March 31, 2019.
Performance
UTHR quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
UTHR Operating expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +26.5% | +28.4% |
3 y3 years | +11.2% | +115.6% |
5 y5 years | -26.3% | +92.0% |
UTHR Operating expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +39.1% | at high | +115.6% |
5 y | 5-year | -26.3% | +43.2% | -24.2% | +136.4% |
alltime | all time | -26.3% | +8255.2% | -67.8% | +4244.2% |
UTHR Operating expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $319.10M(+7.7%) |
Dec 2024 | $1.12B(+26.5%) | $296.30M(+15.0%) |
Sep 2024 | - | $257.60M(-18.8%) |
Jun 2024 | - | $317.20M(+27.6%) |
Mar 2024 | - | $248.50M(-12.4%) |
Dec 2023 | $885.10M(+10.0%) | $283.60M(+33.6%) |
Sep 2023 | - | $212.30M(-3.1%) |
Jun 2023 | - | $219.00M(+28.7%) |
Mar 2023 | - | $170.20M(-33.8%) |
Dec 2022 | $805.00M(-20.1%) | $257.10M(+56.3%) |
Sep 2022 | - | $164.50M(-30.1%) |
Jun 2022 | - | $235.40M(+59.1%) |
Mar 2022 | - | $148.00M(-29.8%) |
Dec 2021 | $1.01B(+28.9%) | $210.80M(+11.9%) |
Sep 2021 | - | $188.30M(+0.6%) |
Jun 2021 | - | $187.10M(-55.5%) |
Mar 2021 | - | $420.90M(+47.8%) |
Dec 2020 | $781.60M(-48.5%) | $284.80M(+111.0%) |
Sep 2020 | - | $135.00M(-31.0%) |
Jun 2020 | - | $195.60M(+17.7%) |
Mar 2020 | - | $166.20M(-24.0%) |
Dec 2019 | $1.52B(+143.5%) | $218.80M(+18.2%) |
Sep 2019 | - | $185.10M(+47.5%) |
Jun 2019 | - | $125.50M(-87.3%) |
Mar 2019 | - | $989.40M(+353.9%) |
Dec 2018 | $623.70M(+4.9%) | $218.00M(+3.2%) |
Sep 2018 | - | $211.20M(+27.7%) |
Jun 2018 | - | $165.40M(+468.4%) |
Mar 2018 | - | $29.10M(-89.3%) |
Dec 2017 | $594.70M(+28.1%) | $272.70M(+166.8%) |
Sep 2017 | - | $102.20M(-19.7%) |
Jun 2017 | - | $127.20M(+37.4%) |
Mar 2017 | - | $92.60M(-55.1%) |
Dec 2016 | $464.40M(-33.4%) | $206.40M(+41.4%) |
Sep 2016 | - | $146.00M(+35.9%) |
Jun 2016 | - | $107.40M(+2234.8%) |
Mar 2016 | - | $4.60M(-98.0%) |
Dec 2015 | $697.80M(+11.9%) | $224.60M(-3016.9%) |
Sep 2015 | - | -$7.70M(-104.8%) |
Jun 2015 | - | $159.40M(-50.4%) |
Mar 2015 | - | $321.50M(+111.5%) |
Dec 2014 | $623.80M(-10.0%) | $151.98M(-52.7%) |
Sep 2014 | - | $321.38M(+198.2%) |
Jun 2014 | - | $107.77M(+152.6%) |
Mar 2014 | - | $42.66M(-84.7%) |
Dec 2013 | $693.36M(+84.8%) | $278.73M(+67.0%) |
Sep 2013 | - | $166.86M(+32.4%) |
Jun 2013 | - | $125.98M(+3.4%) |
Mar 2013 | - | $121.79M(+57.0%) |
Dec 2012 | $375.13M(+11.5%) | $77.55M(-42.0%) |
Sep 2012 | - | $133.78M(+48.1%) |
Jun 2012 | - | $90.36M(+23.0%) |
Mar 2012 | - | $73.45M(-30.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $336.50M(-4.9%) | $106.34M(+39.8%) |
Sep 2011 | - | $76.09M(+58.2%) |
Jun 2011 | - | $48.10M(-54.6%) |
Mar 2011 | - | $105.97M(-18.4%) |
Dec 2010 | $353.91M(+18.6%) | $129.82M(+51.1%) |
Sep 2010 | - | $85.93M(+99.9%) |
Jun 2010 | - | $42.98M(-47.4%) |
Mar 2010 | - | $81.75M(-16.2%) |
Dec 2009 | $298.53M(-10.5%) | $97.61M(+34.2%) |
Sep 2009 | - | $72.72M(-6.8%) |
Jun 2009 | - | $78.02M(+55.5%) |
Mar 2009 | - | $50.18M(-75.1%) |
Dec 2008 | $333.49M(+82.9%) | $201.62M(+309.5%) |
Sep 2008 | - | $49.23M(+16.6%) |
Jun 2008 | - | $42.23M(+4.5%) |
Mar 2008 | - | $40.41M(-34.8%) |
Dec 2007 | $182.38M(+60.5%) | $61.94M(+60.0%) |
Sep 2007 | - | $38.72M(+0.7%) |
Jun 2007 | - | $38.44M(-11.2%) |
Mar 2007 | - | $43.28M(+15.3%) |
Dec 2006 | $113.62M(+87.2%) | $37.52M(+51.2%) |
Sep 2006 | - | $24.81M(+1.3%) |
Jun 2006 | - | $24.48M(-8.6%) |
Mar 2006 | - | $26.80M(+66.1%) |
Dec 2005 | $60.71M(+16.5%) | $16.13M(+7.2%) |
Sep 2005 | - | $15.04M(-4.3%) |
Jun 2005 | - | $15.72M(+13.8%) |
Mar 2005 | - | $13.81M(+5.9%) |
Dec 2004 | $52.13M(-10.2%) | $13.05M(+7.5%) |
Sep 2004 | - | $12.14M(-4.3%) |
Jun 2004 | - | $12.69M(-11.1%) |
Mar 2004 | - | $14.26M(-9.9%) |
Dec 2003 | $58.08M(+36.1%) | $15.83M(+5.4%) |
Sep 2003 | - | $15.03M(+1.6%) |
Jun 2003 | - | $14.79M(+18.8%) |
Mar 2003 | - | $12.44M(-8.8%) |
Dec 2002 | $42.67M(-13.9%) | $13.64M(+31.3%) |
Sep 2002 | - | $10.39M(-5.8%) |
Jun 2002 | - | $11.03M(+44.9%) |
Mar 2002 | - | $7.61M(-26.7%) |
Dec 2001 | $49.53M(-39.5%) | $10.38M(-15.9%) |
Sep 2001 | - | $12.35M(-8.9%) |
Jun 2001 | - | $13.56M(+2.5%) |
Mar 2001 | - | $13.23M(-57.5%) |
Dec 2000 | $81.84M(+137.9%) | $31.15M(+194.5%) |
Sep 2000 | - | $10.57M(-65.5%) |
Jun 2000 | - | $30.67M(+224.4%) |
Mar 2000 | - | $9.45M(+13.9%) |
Dec 1999 | $34.40M(+156.7%) | $8.30M(+15.3%) |
Sep 1999 | - | $7.20M(+14.3%) |
Jun 1999 | - | $6.30M(-49.2%) |
Mar 1999 | - | $12.40M |
Dec 1998 | $13.40M | - |
FAQ
- What is United Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for United Therapeutics?
- What is United Therapeutics annual operating expenses year-on-year change?
- What is United Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for United Therapeutics?
- What is United Therapeutics quarterly operating expenses year-on-year change?
What is United Therapeutics annual total operating expenses?
The current annual operating expenses of UTHR is $1.12B
What is the all time high annual operating expenses for United Therapeutics?
United Therapeutics all-time high annual total operating expenses is $1.52B
What is United Therapeutics annual operating expenses year-on-year change?
Over the past year, UTHR annual total operating expenses has changed by +$234.50M (+26.49%)
What is United Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of UTHR is $319.10M
What is the all time high quarterly operating expenses for United Therapeutics?
United Therapeutics all-time high quarterly total operating expenses is $989.40M
What is United Therapeutics quarterly operating expenses year-on-year change?
Over the past year, UTHR quarterly total operating expenses has changed by +$70.60M (+28.41%)